Search

everythinglearnresearchcommunity

for

Search:↓

Cyproterone acetate effectively treats sexual disorders by reducing sexual functions and is generally well-tolerated.

Intramuscular cyproterone acetate effectively treats hirsutism and improves skin conditions in women with hyperandrogenism.

Hormone therapy for excessive hair growth is as good with GnRHa as with high-dose CPA, but GnRHa has longer-lasting results.

ICP5249 helps hair grow by activating a specific cell pathway.

Mixed coconut oil/solvent is suitable for cyproterone acetate injections, but more safety checks are needed.

GMG-43AC may help reduce unwanted hair growth and treat certain hair loss conditions.

Cyproterone acetate is used to treat conditions like prostate cancer, early puberty, excessive sexual drive, and female androgenization by affecting androgen functions and suppressing certain hormones.

Cyproterone acetate is effective for acne but less so for hirsutism and alopecia, with some side effects and quick menstrual cycle recovery after treatment.

Cyproterone acetate implants were more effective at reducing facial hair and improving skin in severe hirsutism than oral treatment.

CB-03-01 is a promising skin cream for treating hormone-related skin problems without causing harmful body-wide effects.

Kojyl cinnamate ester derivatives can promote hair growth by increasing adiponectin production in fat tissues.

Cyproterone acetate is effective for treating hirsutism and acne but less so for hair loss, with side effects similar to birth control pills.

IMTA can help regrow hair in severe alopecia areata when JAK inhibitors don't work well.

Repaglinide-loaded liponiosomal hybrids improve blood sugar control and insulin release better than regular Repaglinide.

Cyproterone acetate is used to treat conditions like prostate cancer, early puberty, excessive sexual drive, and female androgenization by blocking male sex hormones.

GLP-1 receptor agonists help with weight loss but need to be combined with other treatments for best results.

AMP-303 safely increases hair growth in men with hair loss.

Adults with classic congenital adrenal hyperplasia value medication that prevents weight gain from glucocorticoids the most.

Ac-GFFY-IGF peptide is a promising, safe, and effective treatment for hair loss, better than current options.

Cyproterone acetate at 2mg daily is as effective as higher doses for treating excessive hair growth in women.

GLP-1 receptor agonists can cause skin and hair issues due to rapid weight loss, but these can be managed with proper care and treatments.

The JCCP's Premises Standards aim to make non-surgical cosmetic treatments safer and higher quality.

Metyrapone effectively stabilizes severe Cushing's disease symptoms before surgery.

The drug IPI-926 is safe at 160 mg daily and may help treat certain tumors, especially basal cell carcinoma.

GLP-1 receptor agonists, like Dulaglutide, Liraglutide, and Semaglutide, have potential benefits beyond the pancreas, including neuroprotection, pain suppression, cardiovascular protection, obesity management, and cancer treatment, but there are concerns about pancreatitis and pancreatic cancer risks.

Metyrapone can effectively treat Cushing's Disease even if the mass causing it is not found.

Brepocitinib effectively reduces inflammation and improves symptoms in cicatricial alopecia with good safety.

Men with early-onset hair loss are less responsive to bromocriptine's heart and metabolism benefits.

Cyproterone acetate works similarly to other treatments for hirsutism, but more research is needed.